Skip to main content

#151385

Anti-IgD [IgD26]

Cat. #151385

Anti-IgD [IgD26]

Cat. #: 151385

Unit size: 100 ug

Availability: 3-4 weeks

Target: Immunoglobulin D (IgD)

Class: Monoclonal

Application: FACS ; IHC

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Jacqueline Cordell

Institute: University of Oxford

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-IgD [IgD26]
  • Research fields: Immunology;Stem cell biology
  • Clone: IgD26
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS ; IHC
  • Description: IgD26 may be used as a primary or secondary antibody.
  • Immunogen: IgD purified from human myeloma serum
  • Isotype: IgG1
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: Immunoglobulin D (IgD)
  • Target background: IgD26 may be used as a primary or secondary antibody.

Applications

  • Application: FACS ; IHC

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: RPMI 1640 + 10% FCS + penicillin (100U/ml) + streptomycin (100mg/l) + glutamine (2mM) + HAT
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Naiem M et al. l982. J Immunol Meth 50:145-60. PMID: 6806388 Taylor CR, Mason DY 1974. Clin Exp Immunol 18:417-29. PMID: 4219910

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.